Ascentage Pharma Group International
AAPGV - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.43B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.43 Billion |
|---|---|
| Enterprise Value | $5.70 Billion |
| Earnings per Share | $-1.34 |
| Beta | 1.1 |
| Outstanding Shares | 312,371,926 |
Return
| Return on Equity | -468.36% |
|---|---|
| Return on Assets | -80.41% |
| Return on Invested Capital | -184.55% |
Valuation & Multiples
| P/E Ratio | -6.63 |
|---|---|
| PEG | -18.05 |
| Price to Sales | 5.79 |
| Price to Book Ratio | 17.38 |
| Enterprise Value to Revenue | 5.57 |
| Enterprise Value to EBIT | -2.27 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.38 |
| Debt to Equity | 3.89 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Ascentage Pharma Group International
767 employees
CEO: Dajun Yang
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical cond...